Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Vibrance-mg: clinical trial of nipocalimab in pediatric myasthenia gravis
This cycle also recruits more white blood cells to the joint, which accelerates the inflammatory process
Commercial Development: In August 2025, Jocasta Neuroscience raised $35 million in Series A funding to advance JN-0413, a proprietary -klotho formulation, through Phase 1 trials with IND submission planned for Q4 2026
view test results Secured Payment All products are for laboratory research purposes only
In a human study published that same year, Khavinson and colleagues observed that elderly human subjects who received epithalamin treatment for two to three years experienced a 1.6-1.8 fold decreased mortality rate compared with a control group
Their testimonials are, effectively, advertisements
US$ 22.06
US$ 28.66
US$ 28.91
US$ 22.86
US$ 22.78
US$ 26.95
US$ 22.61
US$ 28.73
US$ 20.78
US$ 25.42
US$ 29.40
US$ 28.40
US$ 21.30
US$ 27.42
